Ospomyv, a biosimilar to Prolia, is indicated for postmenopausal women and men at high risk of fracture, while Xbryk, a biosimilar to Xgeva, is indicated for preventing skeletal-related events in ...

The biosimilar was approved to treat osteoporosis in postmenopausal women at high risk for fracture ... related events for people with multiple myeloma or bone metastases from solid tumors ...

Inside most of your bones is a soft, spongy tissue called bone marrow ... causing pain and fractures. Treatments for multiple myeloma target the cancer cells as well as the symptoms.

Multiple myeloma symptoms include bone pain or fractures, backache, frequent infections, weight loss, fatigue, and other conditions. We diagnose multiple myeloma by doing blood, urine, bone marrow, ...